DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
+296%
US · US
KO.US latest organized financial period shows revenue grew +1.87% YoY and net income grew +23.29% YoY. Current price is about 78.79 USD, while the model base case is about 23.8 USD; the current price sits +231% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:26
Hover each model row to inspect formulas and inputs.
+231%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
+296%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
-15.27%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly 20.3% annualized FCF growth.
Estimates earnings power value without assuming growth.
+231%
Updated: 2026/04/29 15:26
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Asset impairment | Impairment | -9M USD | Medium |
| 2025/12/31 | Business sale gain/loss | Asset sale gain/loss | 28M USD | Medium |
| 2025/12/31 | Litigation settlement | Litigation | -8M USD | Medium |
| 2024/12/31 | Asset impairment | Impairment | -149M USD | Medium |
| 2024/12/31 | Litigation settlement | Litigation | -5M USD | Medium |
| 2023/12/31 | Asset impairment | Impairment | -109M USD | Medium |
| 2023/12/31 | Litigation settlement | Litigation | -25M USD | Medium |
| 2022/12/31 | Asset impairment | Impairment | -45M USD | Medium |
| 2022/12/31 | Restructuring charges | Restructuring | -30M USD | Medium |
| 2021/12/31 | Asset impairment | Impairment | -62M USD | Medium |
| 2021/12/31 | Litigation settlement | Litigation | -24M USD | Medium |
| 2020/12/31 | Asset impairment | Impairment | -458M USD | Medium |
| 2025/09/26 | Litigation settlement | Litigation | -9M USD | Medium |
| 2025/06/27 | Litigation settlement | Litigation | -6M USD | Medium |
| 2025/03/28 | Litigation settlement | Litigation | -2M USD | Medium |
| 2024/09/27 | Litigation settlement | Litigation | -8M USD | Medium |
| 2024/06/28 | Litigation settlement | Litigation | -5M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 48B USD | 13B USD | 13B USD | 5B USD | 3.04 | 3.04 |
| 2024/12/31 | Annual | 47B USD | 11B USD | 11B USD | 5B USD | 2.46 | 2.5 |
| 2023/12/31 | Annual | 46B USD | 11B USD | 11B USD | 10B USD | 2.47 | 2.5 |
| 2022/12/31 | Annual | 43B USD | 10B USD | 10B USD | 10B USD | 2.19 | 2.21 |
| 2021/12/31 | Annual | 39B USD | 10B USD | 10B USD | 11B USD | 2.25 | 2.27 |
Total revenue recognized in each fiscal year.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.